Literature DB >> 10512433

Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration.

P A Lotke1, P Barth, J P Garino, E F Cook.   

Abstract

Efforts to avoid complications associated with transfusion of allogeneic blood have increased the use of preoperatively donated autologous blood (PAB). A major controversy has arisen: Should the same criteria be used for transfusion of autologous as allogeneic red cells? This study prospectively and randomly compared giving PAB immediately after total knee arthroplasty (TKA), beginning in the recovery room or delaying a transfusion until the patient's hemoglobin had fallen to less than a 9.0 g/dL transfusion trigger point. The results show that patients who received immediate transfusion had fewer nonsurgical complications (P < .002). Because TKAs are associated with an average blood loss of 1,400 mL, we recommend that PAB be used in the immediate postoperative period, especially in the elderly, in whom the risk for cardiac or nonsurgical complications is inherently increased.

Entities:  

Mesh:

Year:  1999        PMID: 10512433     DOI: 10.1016/s0883-5403(99)90216-4

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  10 in total

Review 1.  Anemia in the preoperative patient.

Authors:  Manish S Patel; Jeffrey L Carson
Journal:  Med Clin North Am       Date:  2009-09       Impact factor: 5.456

Review 2.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Authors:  Jeffrey L Carson; Paul A Carless; Paul C Hebert
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 3.  Transfusion thresholds for guiding red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Jane A Dennis; Marialena Trivella; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Dorée; Paul C Hébert
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

4.  Blood loss in patients for total knee arthroplasty.

Authors:  Hiroshi Fujimoto; Toshifumi Ozaki; Kohji Asaumi; Hisayoshi Kato; Keichiro Nishida; Yasuhiro Takahara; Nobuhiro Abe; Hajime Inoue
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-02-19       Impact factor: 4.342

5.  The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture.

Authors:  Ethan A Halm; Jason J Wang; Kenneth Boockvar; Joan Penrod; Stacey B Silberzweig; Jay Magaziner; Kenneth J Koval; Albert L Siu
Journal:  J Orthop Trauma       Date:  2004-07       Impact factor: 2.512

Review 6.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Doree; Paul C Hebert
Journal:  Cochrane Database Syst Rev       Date:  2016-10-12

7.  Debate: transfusing to normal haemoglobin levels will not improve outcome.

Authors:  G Alvarez; P C Hébert; S Szick
Journal:  Crit Care       Date:  2001-03-08       Impact factor: 9.097

Review 8.  Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis.

Authors:  Lars B Holst; Marie W Petersen; Nicolai Haase; Anders Perner; Jørn Wetterslev
Journal:  BMJ       Date:  2015-03-24

9.  Perioperative transfusion threshold and ambulation after hip revision surgery--a randomized trial.

Authors:  Kamilla Nielsen; Pär I Johansson; Benny Dahl; Michael Wagner; Britt Frausing; Jens Børglum; Kenneth Jensen; Jens Stürup; Jesper Hvolris; Lars S Rasmussen
Journal:  BMC Anesthesiol       Date:  2014-10-10       Impact factor: 2.217

Review 10.  Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis.

Authors:  Annemarie B Docherty; Rob O'Donnell; Susan Brunskill; Marialena Trivella; Carolyn Doree; Lars Holst; Martyn Parker; Merete Gregersen; Juliano Pinheiro de Almeida; Timothy S Walsh; Simon J Stanworth
Journal:  BMJ       Date:  2016-03-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.